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Highlights 11 
 We measured IL-6 in saliva, venous and capillary plasma pre and post 12 
exercise. 13 
 Salivary IL-6 did not correlate to venous IL-6 at rest or post exercise. 14 
 Capillary plasma IL-6 correlated to venous plasma in response to exercise. 15 
 Capillary plasma responses may be reflective of systemic IL-6 responses to 16 
exercise.  17 
 18 
Abstract 19 
IL-6 plays a mechanistic role in conditions such as metabolic syndrome, chronic 20 
fatigue syndrome and clinical depression and also plays a major role in inflammatory 21 
and immune responses to exercise. The purpose of this study was to investigate the 22 
levels of resting and post exercise IL-6 when measured in venous plasma, saliva and 23 
capillary plasma. Five male and five females completed 2 separate exercise trials, 24 
both of which involved standardized exercise sessions on a cycle ergometer. Venous 25 
blood and saliva samples were taken immediately before and after Trial A, venous 26 
and capillary blood samples were taken immediately before and after Trial B. IL-6 27 
values were obtained using a high-sensitivity enzyme-linked immunosorbent assay 28 
(ELISA). In Trial A venous plasma IL-6 increased significantly from 0.4±0.14 pg/ml 29 
to 0.99±0.29 pg/ml (P<0.01) while there was no increase in salivary IL-6. Venous 30 
plasma and salivary IL-6 responses were not correlated at rest, post exercise or when 31 
expressed as an exercise induced change. In Trial B venous and capillary plasma IL-6 32 
increased significantly (venous: 0.22±0.18 to 0.74±0.28 pg/ml (P=<0.01); capillary: 33 
0.37±0.22 to 1.08±0.30 pg/ml (P<0.01). Venous and capillary plasma responses did 34 
not correlate at rest (r=0.59, P=0.07) but did correlate post exercise (r=0.79, 35 
P=>0.001) and when expressed as an exercise induced change (r=0.71, P=0.02). 36 
Saliva does not appear to reflect systemic IL-6 responses, either at rest or in response 37 
to exercise. Conversely, capillary plasma responses are reflective of systemic IL-6 38 
responses to exercise. 39 
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 41 
1. Introduction 42 
Interleukin-6 (IL-6) is an important biomarker in metabolic syndrome [1], and is also 43 
reported to play a mechanistic role in the development of many disorders, including 44 
chronic fatigue syndrome [2] and clinical depression [3]. The discovery that IL-6 is 45 
released directly from exercising muscle [4] has led to an increase in the volume of 46 
research investigating the impact of exercise on plasma concentrations of IL-6. IL-6 is 47 
also considered to play a major role in a number of signaling pathways that govern 48 
metabolic, inflammatory and immune responses to exercise stimuli [1,5,6].  49 
IL-6 is typically measured in the serum or plasma from whole blood samples, which 50 
are obtained using standard venipuncture techniques or, in the case of repeated 51 
samples, via venous catheter. Whole blood is generally considered the body fluid that 52 
most accurately represents the systemic response to a given stimulus. Importantly, 53 
however, venous blood collection is invasive and can prove impractical in situations 54 
where access is difficult [7].  55 
The potential to use saliva or capillary blood samples in the place of traditional 56 
venous blood samples could be advantageous in settings where venous blood 57 
sampling is practically difficult. Some salivary proteins (such as cortisol and 58 
testosterone) are directly derived from the blood and therefore are considered to 59 
similarly reflect systemic responses. Thus, salivary levels are often used as surrogates 60 
for blood-borne levels of these analytes [8]. Capillary blood sampling is regularly 61 
utilized to measure health-related biomarkers (e.g. blood glucose, cholesterol, 62 
triglyceride levels), and is also used to measure exercise-related biomarkers (e.g. 63 
blood lactate, glucose, haematocrit, haemoglobin) in research and applied sports 64 
science environments. However, research into the validity of such measures has 65 
demonstrated the importance of evaluating the relationship between measurements 66 
obtained from venous versus capillary blood samples, and hence the standardization 67 
of the procedures involved in both sampling and analysis [9,10].  68 
Several studies have investigated the potential for saliva to be used as a surrogate of 69 
blood to measure IL-6. Sjögren et al. (2005) found that while serum and salivary IL-6 70 
levels were not correlated with each other, they were both negatively related to 71 
psychosocial resources and positively related to psychosocial risk factors [11]. 72 
Minetto et al. (2005) demonstrated that there was no correlation between salivary and 73 
plasma IL-6 concentrations at rest or in response to exercise [12]; however the same 74 
group later showed [13] that the sample collection method used in the earlier 75 
experiment may in part have accounted for this lack of correlation. Cox et al. (2008) 76 
measured plasma and salivary IL-6 in a cohort of 45 athletes; while they found no 77 
correlation at rest, the authors suggested it was possible that the pattern of regulation 78 
could be related in response to exercise [14]. 79 
Importantly, to our knowledge, no study has compared the cytokine responses to 80 
exercise in capillary and venous blood. IL-6 remains a regularly measured biomarker 81 
in numerous fields of research, and a more practical and convenient method of 82 
sampling would facilitate less invasive and time-consuming procedures.  83 
Therefore, this study aimed to investigate the relationship between IL-6 levels as 84 
measured in venous plasma, saliva and capillary plasma, both at rest and in response 85 
to exercise. 86 
 87 
2. Materials and Methods 88 
 89 
2.1 Participants 90 
 91 
Ten healthy active individuals (5 male, 5 female) aged 25.5 ± 7.8 yr (mean ± SD) 92 
gave informed consent to participate in the study. Subjects completed health/physical 93 
activity questionnaires to ensure normal dietary and exercise habits before each test. 94 
All participants were free of injury and illness prior to and throughout the study.  95 
Ethical approval was obtained via ethics committee and conformed to the declaration 96 
of Helsinki. 97 
 98 
2.2 Experimental Procedure 99 
 100 
Participants were tested for maximal aerobic capacity using an incremental exercise 101 
test on an electromagnetically-braked cycle ergometer (Lode Excalibur, Groningen, 102 
Netherlands). Expired gases were measured using an online gas analyser (OxyconPro, 103 
Erich Jaeger GMBH & Co., Hoechberg, Germany), and heart rate was measured 104 
continuously via short-range telemetry (RS400, Polar Electro, Finland). Each stage of 105 
the incremental exercise lasted 3 minutes, with required power output being increased 106 
by 30W at each stage until volitional exhaustion. Males began the test at a required 107 
power output of 100W while females began at 50W. peak was recorded as the 108 
highest 30-s period of oxygen consumption. Oxygen consumption values obtained 109 
during the incremental test were used to plot a linear regression of power output 110 
versus oxygen consumption. This allowed the calculation of individual power outputs 111 
for the subsequent exercise session. 112 
In both trials (A and B) participants completed the same standardized bout of high 113 
intensity interval exercise on a cycle ergometer within 1 week of incremental exercise 114 
testing: 5 x 4 minute intervals at 80% peak interspersed with 3-minute intervals at 115 
50% peak. During Trial A venous blood and saliva samples were collected 116 
immediately pre- and post-exercise. During Trial B venous and capillary blood 117 
samples were taken immediately pre- and post-exercise. Each participant performed 118 
both exercise trials at the same time of day and with a minimum of 2 days rest 119 
prior to each trial. Expired gases and heart rate were measured continuously 120 
throughout each exercise session.  121 
  122 
2.3 Sample collection/handling 123 
 124 
Venous blood samples were collected into K3EDTA tubes (Greiner Bio-one; 125 
Frickenhausen, Germany). Whole mixed unstimulated saliva samples (approx. 1ml) 126 
were collected by passively drooling though a straw [13]. Saliva samples were 127 
aliquoted and stored at -80°C until further analysis. When thawed, saliva samples 128 
were briefly centrifuged to avoid particulate matter and diluted 1:4 based upon prior 129 
linearity and recovery experiments (data not shown). Prior to capillary blood 130 
collection, participants briefly submerged their hand in warm water to aid blood flow 131 
to the fingertip, whereupon 600μl of whole blood was obtained using 3 heparinized 132 
2OV
2OV
2OV
200μl microvette capillary blood collection tubes (Sarstedt, Germany) – it should be 133 
noted that this process took up to 10 minutes to complete. Nevertheless, for all 134 
sample-types, samples were collected within a maximum of 15 minutes post-exercise. 135 
Whole blood samples were fractionated by centrifugation (10min; 3,000xG), and the 136 
resulting plasma was aliquoted and stored at -80°C until analysis. 137 
 138 
2.4 Enzyme-linked immunosorbent assays 139 
 140 
Plasma (both venous and capillary-derived) and salivary IL-6 concentrations were 141 
analysed in duplicate using high sensitivity enzyme-linked immunosorbent assays 142 
(ELISA) (Quantikine HS; R&D Systems Ltd., Abingdon, UK). The IL-6 assay has a 143 
detection limit of 0.039 pg/ml and an inter/intra-assay coefficient of variation (CV) of 144 
<10% across the range 0.15–10 pg/ml. Protein concentrations were determined in 145 
relation to a four-parameter standard curve (GraphPad Prism, San Diego California, 146 
USA) 147 
 148 
2.5 Statistical analysis 149 
 150 
All data are presented as mean±standard deviation (SD) unless otherwise stated. 151 
Results were evaluated using a linear mixed-model ANOVA with the factors ‘time’ 152 
and ‘sample-type’ included as factors. Student–Newman–Keuls (SNK) post-hoc tests 153 
were performed where appropriate. Pearson’s correlation analyses were used to 154 
investigate the relationships between IL-6 concentrations measured in venous, 155 
salivary and capillary samples. Ninety-percent confidence intervals (90% CI) were 156 
used to indicate the precision of estimates. SPSS 20.0 was used for all statistical 157 
analysis. 158 
 159 
3. Results 160 
In Trial A plasma IL-6 increased significantly in response to exercise from 0.4±0.14 161 
pg/ml to 0.99±0.29 pg/ml (P<0.01) (Fig. 1A). There was no significant change in 162 
salivary IL-6 pre to post exercise (P=0.12) (Fig. 1B). There was no correlation 163 
between plasma and salivary IL-6, whether expressed as an exercise-induced change 164 
(r=-0.07, P=0.85, 90% CI= -0.56 to 0.50) or the discrete pre-exercise (r=-0.38, 165 
P=0.27, 90% CI= -0.77 to 0.21,) and post-exercise (r=0.49, P=0.15, 90% CI= -0.09 to 166 
0.82) measurements.  167 
In Trial B both venous and capillary plasma IL-6 increased significantly (venous: 168 
0.22±0.18 to 0.74±0.28 pg/ml (P=<0.01); capillary: 0.37±0.22 to 1.08±0.30 pg/ml 169 
(P<0.01) (Figs. 1C/D)). Venous and capillary plasma IL-6 did not correlate at rest 170 
(r=0.59, P=0.07, 90% CI 0.06 to 0.86), but exhibited significant correlations both 171 
post-exercise (r=0.79, P=>0.001, 90% CI= 0.42 to 0.93) and when expressed as an 172 
exercise-induced change (r=0.71, P=0.02, 90% CI=0.26 to 0.91). 173 
 174 
Figure 1. IL-6 responses to standardised bouts of high intensity intermittent exercise 175 
in 10 matched individuals (venous (A) and salivary (B) IL-6 values [trial A], and 176 
venous (C) and capillary (D) IL-6 values [trial B]). Grey lines represent individual 177 
responses; black lines represent cohort-means (*=P>0.05). 178 
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 179 
Figure 2. The effect of sample type and procedure on IL-6 concentration. 180 
Correlations between venous and salivary IL-6 at rest (A), post–exercise (B), and 181 
when expressed as a pre to post exercise change (C). Venous and capillary IL-6 182 
correlation at rest (D), post–exercise (E) and when expressed as a pre-versus-post 183 
exercise change (F). 184 
 185 
4. Discussion 186 
In this study the exercise induced increase in IL-6 was observed in plasma and 187 
capillary samples but not in saliva (Fig.1). This study confirms the modest increases 188 
in plasma IL-6 seen with similar high intensity interval exercise protocols [15]. 189 
Capillary and venous plasma IL-6 correlated post-exercise and when expressed as an 190 
exercise-induced change, but not at rest (Figs. 2 D-F). Capillary plasma IL-6 values 191 
were consistently higher than those in venous plasma (mean differences: 0.15 and 192 
0.34 pg/ml at rest and post-exercise, respectively). However there was no significant 193 
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difference between the exercise-induced increase in IL-6 between capillary and 194 
venous samples. The higher values from the capillary samples may be due to a small 195 
local inflammatory response to the action of the pinprick, and the fact that the blood is 196 
obtained from the capillaries surrounding the potential site of inflammation rather 197 
than from the circulation (as with a venous sample). While the correlation between 198 
resting capillary and venous plasma IL-6 approached significance (P=0.07), it should 199 
be noted that the study used a small homogenous (n=10) sample population with very 200 
low resting IL-6 levels, and it is possible that a larger and more diverse cohort of 201 
subjects may have led to a statistically significant correlation. 202 
Salivary IL-6 did not correlate with venous IL-6 at rest, post-exercise or when 203 
expressed as an exercise-induced change (Figs. 2 A-C). This confirms the previous 204 
suggestions [12] that salivary IL-6 does not share similar patterns of regulation to 205 
venous IL-6 in response to exercise, and hence that saliva is not an appropriate 206 
surrogate measure of systemic IL-6. While the working muscle is primarily 207 
responsible for systemic increases in IL-6 in response to exercise [4], it has been 208 
hypothesized that salivary responses are due to local tissue macrophages and the 209 
acinar cells of the salivary glands [11]. Consequently, it is likely that salivary IL-6 is 210 
more reflective of a local inflammatory response than a systemic metabolic response 211 
to an exercise stimulus.  212 
In conclusion, this study confirms previous observations that salivary IL-6 does not 213 
change in response to aerobic exercise [12], and should not be used as a surrogate for 214 
systemic IL-6 responses, either at rest or in response to exercise. Conversely, IL-6 215 
measured from capillary blood appears to be sensitive to exercise, and apparently 216 
shares the same pattern of regulation as is seen in venous blood. However, caution 217 
should be applied when interpreting these preliminary findings and further 218 
investigation is required; in particular, the impact of exercise on capillary IL-6 should 219 
be investigated within different cohorts undergoing a range of different exercise 220 
protocols. 221 
 222 
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